Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof

Details for Australian Patent Application No. 2002333373 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Schaefer Hans-Ludwig; Glombik, Heiner; Frick, Wendelin; Kramer, Werner

Agent Watermark

Pub. Number AU-B-2002333373

PCT Number PCT/EP02/08908

PCT Pub. Number WO2003/018024

Priority 101 40 169.8 22.08.01 DE; 101 42 456.6 31.08.01 DE

Filing date 9 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 14 December 2006

International Classifications

C07D 337/08 (2006.01) Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 101 40 169.8 22.08.01 DE; 101 42 456.6 31.08.01 DE

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002333373

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

14 December 2006 Application Accepted

  Published as AU-B-2002333373

19 April 2007 Standard Patent Sealed

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333374-Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use

2002333372-Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof